Tuesday 25 September 2018 5:00pm to 8:45pm
About
Date: Tuesday, 25th September 2018
Time: 17:00 - 20:30
Location: Milstein Building, Granta Park, Cambridge, CB21 6GH
This meeting is hosted by AstraZeneca and highlights a range of perspectives and contributions to the development of therapeutics using genomic approaches to disease.
The Cambridge New Therapeutics Forum is open to all scientists researching new therapeutics in Cambridge and the local area. The purpose of the CamNTF is to promote interactions between scientists from academia & industry in order to improve opportunities for biotechnology research and development
17:30 – Arrival, Registration, Tea & Coffee
18:00 – Welcome, Dr Mark Fidock, VP and Head of Precision Medicine Laboratories
18:10 – Prof. Slave Petrovski, Honorary Associate Professor, University of Melbourne
Honorary Fellow, University of Cambridge, Vice President & Head of Genome Analytics, AstraZeneca.
Discovering the genetic basis of common disease using innovative approaches in genomic analysis
18:50 – Dr Eleanor Wigmore, Genomics Post Doc Fellows
Investigating the role of GDF15 in human metabolic syndrome
19:00 – Dr Dimitrios Vitsios Genomics Post Doc Fellows
Identifying clinically important non-coding sequence in the human genome
19:10 – Networking and Refreshments
20:00 – Meeting close
Parking will be available for this meeting and you will be directed by staff at the entrance to the Granta Park Campus
Meeting attendance is free but all attendees must register in advance. Spaces are limited, so early registration is encouraged to avoid disappointment.
Click here to book your place.
Follow us on facebook (https://www.facebook.com/camntf/), LinkedIn and Meetup